Avalo Therapeutics Statistics
Total Valuation
AVTX has a market cap or net worth of $10.43 million. The enterprise value is -$99.22 million.
| Market Cap | 10.43M |
| Enterprise Value | -99.22M |
Important Dates
The last earnings date was Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AVTX has 1.03 million shares outstanding. The number of shares has increased by 1,780.17% in one year.
| Shares Outstanding | 1.03M |
| Shares Change (YoY) | +1,780.17% |
| Shares Change (QoQ) | +29.01% |
| Owned by Insiders (%) | 5.74% |
| Owned by Institutions (%) | 4.95% |
| Float | 860,975 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.56 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.52
| Current Ratio | 0.52 |
| Quick Ratio | 0.51 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -56.89 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -288.30% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $76,316 |
| Profits Per Employee | -$7.52M |
| Employee Count | 19 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVTX has paid $13,000 in taxes.
| Income Tax | 13,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.39% in the last 52 weeks. The beta is 1.22, so AVTX's price volatility has been higher than the market average.
| Beta (1Y) | 1.22 |
| 52-Week Price Change | -98.39% |
| 50-Day Moving Average | 11.25 |
| 200-Day Moving Average | 18.05 |
| Relative Strength Index (RSI) | 39.59 |
| Average Volume (30 Days) | 697,439 |
Short Selling Information
The latest short interest is 104,337, so 10.09% of the outstanding shares have been sold short.
| Short Interest | 104,337 |
| Short Previous Month | 153,399 |
| Short % of Shares Out | 10.09% |
| Short % of Float | 12.12% |
| Short Ratio (days to cover) | 0.37 |
Income Statement
In the last 12 months, AVTX had revenue of $1.45 million and -$142.88 million in losses. Loss per share was -$192.60.
| Revenue | 1.45M |
| Gross Profit | 796,000 |
| Operating Income | -51.33M |
| Pretax Income | -142.87M |
| Net Income | -142.88M |
| EBITDA | -140.24M |
| EBIT | -140.40M |
| Loss Per Share | -$192.60 |
Balance Sheet
The company has $110.18 million in cash and no debt, giving a net cash position of $110.18 million or $106.54 per share.
| Cash & Cash Equivalents | 110.18M |
| Total Debt | n/a |
| Net Cash | 110.18M |
| Net Cash Per Share | $106.54 |
| Equity / Book Value | -112.54M |
| Book Value Per Share | -108.83 |
| Working Capital | -104.49M |
Cash Flow
| Operating Cash Flow | -26.83M |
| Capital Expenditures | n/a |
| Free Cash Flow | -26.83M |
| FCF Per Share | -$25.95 |
Margins
Gross margin is 54.90%, with operating and profit margins of -3,539.66% and -9,853.72%.
| Gross Margin | 54.90% |
| Operating Margin | -3,539.66% |
| Pretax Margin | -9,852.83% |
| Profit Margin | -9,853.72% |
| EBITDA Margin | -9,671.66% |
| EBIT Margin | -9,682.62% |
| FCF Margin | -1,850.34% |
Dividends & Yields
AVTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,780.17% |
| Shareholder Yield | -1,780.17% |
| Earnings Yield | -1,303.43% |
| FCF Yield | -244.76% |
Analyst Forecast
The average price target for AVTX is $107.50, which is 965.41% higher than the current price. The consensus rating is "Buy".
| Price Target | $107.50 |
| Price Target Difference | 965.41% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 29, 2023. It was a reverse split with a ratio of 1:240.
| Last Split Date | Dec 29, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:240 |
Scores
AVTX has an Altman Z-Score of -9.88 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.88 |
| Piotroski F-Score | 1 |